Daito Pharmaceutical Co Ltd
TSE:4577
Daito Pharmaceutical Co Ltd
TSE:4577
Price:
2 175
JPY
-2.2%
Market Closed
Market Cap:
33.4B
JPY
Cash Flow Statement
Cash Flow Statement
Daito Pharmaceutical Co Ltd
Daito Pharmaceutical Co Ltd
Currency: JPY
Millions
TTM
| Feb-2011 | May-2011 | Nov-2011 | May-2012 | Nov-2012 | May-2013 | Nov-2013 | May-2014 | Nov-2014 | May-2015 | Nov-2015 | May-2016 | Nov-2016 | May-2017 | Nov-2017 | May-2018 | Nov-2018 | May-2019 | Nov-2019 | May-2020 | Nov-2020 | May-2021 | Nov-2021 | May-2022 | Nov-2022 | May-2023 | Nov-2023 | May-2024 | Nov-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||||||
| Net Income |
1 414
|
1 678
|
2 258
|
2 455
|
2 429
|
2 608
|
2 623
|
2 869
|
3 120
|
3 373
|
3 536
|
3 426
|
3 631
|
3 885
|
4 125
|
4 263
|
4 364
|
4 619
|
5 156
|
5 595
|
6 182
|
5 874
|
6 420
|
6 720
|
5 329
|
5 076
|
4 686
|
4 218
|
3 782
|
|
| Depreciation & Amortization |
1 464
|
2 093
|
2 258
|
2 269
|
2 458
|
2 568
|
2 542
|
2 445
|
2 379
|
2 440
|
2 520
|
2 643
|
2 794
|
2 818
|
2 827
|
2 853
|
2 766
|
2 853
|
2 969
|
2 950
|
2 954
|
3 154
|
3 280
|
3 313
|
3 637
|
3 870
|
3 697
|
3 659
|
4 065
|
|
| Other Non-Cash Items |
111
|
345
|
319
|
110
|
(15)
|
(98)
|
(1)
|
70
|
15
|
45
|
11
|
341
|
350
|
(177)
|
(144)
|
(102)
|
(142)
|
(60)
|
(95)
|
(225)
|
(121)
|
105
|
(40)
|
(174)
|
23
|
30
|
(34)
|
(418)
|
(780)
|
|
| Cash Taxes Paid |
420
|
420
|
750
|
962
|
1 056
|
1 085
|
773
|
725
|
1 097
|
1 129
|
1 268
|
1 412
|
919
|
767
|
1 426
|
1 678
|
1 398
|
1 431
|
1 004
|
811
|
1 794
|
2 088
|
1 883
|
1 924
|
2 207
|
2 411
|
1 611
|
1 265
|
1 262
|
|
| Cash Interest Paid |
130
|
183
|
173
|
159
|
137
|
128
|
113
|
87
|
72
|
57
|
48
|
41
|
32
|
28
|
28
|
24
|
21
|
20
|
16
|
11
|
9
|
8
|
8
|
9
|
13
|
13
|
14
|
40
|
85
|
|
| Change in Working Capital |
(1 578)
|
(1 287)
|
(1 368)
|
(1 491)
|
(2 287)
|
(2 536)
|
(2 173)
|
(2 639)
|
(1 804)
|
(2 119)
|
(2 814)
|
(3 462)
|
(3 389)
|
(1 457)
|
(2 268)
|
(1 549)
|
(1 157)
|
(523)
|
(549)
|
(4 015)
|
(5 560)
|
(3 951)
|
(3 790)
|
(5 488)
|
(5 885)
|
(4 820)
|
(3 387)
|
(2 276)
|
(1 991)
|
|
| Cash from Operating Activities |
1 411
N/A
|
2 829
+100%
|
3 466
+23%
|
3 343
-4%
|
2 585
-23%
|
2 541
-2%
|
2 990
+18%
|
2 745
-8%
|
3 709
+35%
|
3 739
+1%
|
3 253
-13%
|
2 949
-9%
|
3 386
+15%
|
5 070
+50%
|
4 540
-10%
|
5 465
+20%
|
5 830
+7%
|
6 888
+18%
|
7 481
+9%
|
4 306
-42%
|
3 455
-20%
|
5 183
+50%
|
5 871
+13%
|
4 371
-26%
|
3 104
-29%
|
4 156
+34%
|
4 962
+19%
|
5 183
+4%
|
5 076
-2%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||||||
| Capital Expenditures |
(2 373)
|
(3 067)
|
(3 170)
|
(2 936)
|
(2 512)
|
(1 859)
|
(1 995)
|
(2 335)
|
(3 627)
|
(4 919)
|
(3 683)
|
(3 949)
|
(3 961)
|
(2 992)
|
(3 638)
|
(3 874)
|
(3 615)
|
(3 663)
|
(2 962)
|
(2 773)
|
(3 999)
|
(6 350)
|
(5 649)
|
(4 733)
|
(4 722)
|
(5 556)
|
(7 649)
|
(6 276)
|
(7 659)
|
|
| Other Items |
(67)
|
(268)
|
(225)
|
(243)
|
(151)
|
(378)
|
(366)
|
172
|
380
|
325
|
16
|
(67)
|
(63)
|
(20)
|
(48)
|
41
|
74
|
(205)
|
(102)
|
92
|
(13)
|
25
|
287
|
333
|
53
|
(10)
|
12
|
346
|
58
|
|
| Cash from Investing Activities |
(2 440)
N/A
|
(3 335)
-37%
|
(3 395)
-2%
|
(3 179)
+6%
|
(2 663)
+16%
|
(2 237)
+16%
|
(2 361)
-6%
|
(2 163)
+8%
|
(3 247)
-50%
|
(4 595)
-41%
|
(3 667)
+20%
|
(4 015)
-9%
|
(4 024)
0%
|
(3 012)
+25%
|
(3 686)
-22%
|
(3 833)
-4%
|
(3 541)
+8%
|
(3 867)
-9%
|
(3 063)
+21%
|
(2 681)
+12%
|
(4 011)
-50%
|
(6 324)
-58%
|
(5 362)
+15%
|
(4 400)
+18%
|
(4 669)
-6%
|
(5 566)
-19%
|
(7 637)
-37%
|
(5 930)
+22%
|
(7 601)
-28%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
(0)
|
(0)
|
(0)
|
0
|
0
|
1 099
|
0
|
0
|
2 475
|
2 475
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
402
|
2 000
|
3 396
|
1 798
|
309
|
1 514
|
1 397
|
192
|
(2)
|
(1 176)
|
(1 174)
|
|
| Net Issuance of Debt |
402
|
(170)
|
605
|
(165)
|
803
|
859
|
(1 862)
|
(1 769)
|
(1 349)
|
(1 498)
|
(1 283)
|
830
|
1 024
|
(1 500)
|
(472)
|
(1 130)
|
(1 797)
|
(2 447)
|
(3 429)
|
(1 857)
|
(1 734)
|
285
|
360
|
55
|
2 990
|
1 357
|
2 222
|
1 901
|
3 287
|
|
| Cash Paid for Dividends |
(179)
|
(179)
|
(180)
|
(179)
|
(268)
|
(268)
|
(294)
|
(296)
|
(297)
|
(466)
|
(357)
|
(375)
|
(376)
|
(375)
|
(411)
|
(413)
|
(414)
|
(451)
|
(475)
|
(502)
|
(595)
|
(658)
|
(631)
|
(660)
|
(844)
|
(931)
|
(863)
|
(907)
|
(940)
|
|
| Other |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(8)
|
(10)
|
71
|
72
|
98
|
97
|
(1)
|
(1)
|
(0)
|
8
|
8
|
(0)
|
(0)
|
82
|
80
|
(3)
|
(2)
|
(3)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
223
N/A
|
(349)
N/A
|
424
N/A
|
(344)
N/A
|
535
N/A
|
1 691
+216%
|
(1 057)
N/A
|
(2 065)
-95%
|
830
N/A
|
503
-39%
|
(1 650)
N/A
|
526
N/A
|
720
+37%
|
(1 778)
N/A
|
(786)
+56%
|
(1 544)
-97%
|
(2 212)
-43%
|
(2 898)
-31%
|
(3 494)
-21%
|
(350)
+90%
|
1 066
N/A
|
1 425
+34%
|
119
-92%
|
989
+732%
|
3 541
+258%
|
616
-83%
|
1 354
+120%
|
(183)
N/A
|
1 172
N/A
|
|
| Change in Cash | ||||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(2)
|
(1)
|
3
|
1
|
3
|
132
|
186
|
71
|
(9)
|
(15)
|
5
|
(28)
|
(49)
|
(14)
|
21
|
5
|
(19)
|
(15)
|
(13)
|
(10)
|
(1)
|
6
|
4
|
48
|
85
|
20
|
24
|
51
|
10
|
|
| Net Change in Cash |
(807)
N/A
|
(856)
-6%
|
499
N/A
|
(179)
N/A
|
461
N/A
|
2 126
+362%
|
(242)
N/A
|
(1 413)
-484%
|
1 283
N/A
|
(367)
N/A
|
(2 059)
-461%
|
(568)
+72%
|
33
N/A
|
266
+699%
|
89
-67%
|
94
+6%
|
58
-38%
|
108
+85%
|
910
+743%
|
1 265
+39%
|
509
-60%
|
289
-43%
|
632
+119%
|
1 008
+60%
|
2 061
+104%
|
(774)
N/A
|
(1 297)
-68%
|
(879)
+32%
|
(1 343)
-53%
|
|
| Free Cash Flow | ||||||||||||||||||||||||||||||
| Free Cash Flow |
(962)
N/A
|
(238)
+75%
|
297
N/A
|
407
+37%
|
74
-82%
|
682
+828%
|
996
+46%
|
410
-59%
|
82
-80%
|
(1 180)
N/A
|
(431)
+63%
|
(1 000)
-132%
|
(575)
+42%
|
2 078
N/A
|
902
-57%
|
1 592
+77%
|
2 215
+39%
|
3 225
+46%
|
4 519
+40%
|
1 533
-66%
|
(544)
N/A
|
(1 167)
-115%
|
221
N/A
|
(362)
N/A
|
(1 618)
-347%
|
(1 400)
+13%
|
(2 687)
-92%
|
(1 093)
+59%
|
(2 583)
-136%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
